Hot Features
Premium
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Period:
Draw Mode:
| Volume | 0.00 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Innovation1 Biotech Inc (CE) | IVBT | OTCMarkets | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 0.0008 | 19:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.0008 | 0.0008 |
| Trades | Shares Traded | Average Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0.00 | - | 0.0008 - 1.20 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| - | 0 | US$ 0.0008 | USD |
Innovation1 Biotech Inc (CE) Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 0 | 20.47M | 83.92k | 0 | -14.08M | -0.63 | 0.00 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Innovation1 Biotech (CE) News
| Date | Time | Source | News Article |
|---|---|---|---|
| 1/17/2024 | 13:11 | Edgar (US Regulatory) | Form NT 10-Q - Notification of inability to timely file Form.. |
| 12/13/2023 | 15:44 | Edgar (US Regulatory) | Form 8-K - Current report |
| 11/07/2023 | 15:01 | Edgar (US Regulatory) | Form 8-K - Current report |
| 10/16/2023 | 06:00 | Edgar (US Regulatory) | Form 8-K - Current report |
| 9/13/2023 | 11:23 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 9/08/2023 | 15:05 | Edgar (US Regulatory) | Form 8-K - Current report |
| 8/11/2023 | 15:31 | Edgar (US Regulatory) | Form 8-K - Current report |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical IVBT Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 1 Month | 0.0008 | 0.0008 | 0.0008 | 0.0008 | 620 | 0.00 | 0.00% |
| 3 Months | 0.0008 | 0.0008 | 0.0008 | 0.0008 | 620 | 0.00 | 0.00% |
| 6 Months | 0.05399 | 0.2345 | 0.0008 | 0.0778904 | 1,000 | -0.05319 | -98.52% |
| 1 Year | 0.232 | 1.20 | 0.0008 | 0.5958799 | 4,269 | -0.2312 | -99.66% |
| 3 Years | 2.00 | 3.73 | 0.0008 | 0.4124035 | 3,466 | -2.00 | -99.96% |
| 5 Years | 2.00 | 3.73 | 0.0008 | 0.4124035 | 3,466 | -2.00 | -99.96% |
Innovation1 Biotech (CE) Description
| Innovation1 Biotech is a drug discovery company focused on modified Schedule 1 molecules of botanical origin, where there is the opportunity to create safer and more effective derivatives for treatment of neurologic, psychiatric, and dermatologic disorders. Led by experts in drug development, medicinal chemistry, and capital markets, Innovation1 is capitalizing and addressing the shortcomings of natural botanicals by transforming them into fully synthetic drugs that are safely, reliably, and consistently delivered for medical use and commercialization. The Company has a portfolio addressing five independent clinical indications, all fully synthetic prodrugs without connection to botanical sourcing, wherein the current therapeutic armamentarium is inadequate or non-existent. |
